fbpx

Diagnosed With Lung Cancer?

In order to thrive, you need to have all of the tools at your fingertips, and that includes evidence-based therapies that go beyond conventional oncology.

Download our FREE PDF guide filled with evidence-based therapies that you can start today to manage your Lung Cancer. Click the orange button to get your download now.

Where you Treat Your Lung Cancer Makes a Difference!

Share Button

Lung Cancer Patients treated at academic centers also had a lower risk of death;4-year Overall Survival rates were 25% and 19% among patients treated at academic and non-academic centers, respectively

Over the years I have learned that hospitals and oncologists often specialize in one or more cancers. While this may sound obvious, this idea didn’t occur to me when I was diagnosed with my own cancer in early 1994. I had an operation to remove a “growth,” was told that the “growth” was multiple myeloma and off I went. When my oncologist suggested I undergo an autologous stem cell transplant checking to see if my hospital, University Hospitals of Cleveland, was experienced at this complicated procedure never entered my mind.

Image result for image of lung cancer

If you have been diagnosed with lung cancer, at any stage, studies show that where you are treated can make a significant difference. According to the study linked and excerpted below, lung cancer patients can expect to live, on average, more than 25% longer if you are treated at an academic center rather than a non-academic center.

Further, there are a host of evidence-based, non-conventional therapies that research shows enhances lung cancer chemotherapy and radiation as well.

Have you been diagnosed with lung cancer? I am both a cancer survivor and cancer coach. To learn more about both conventional and non-conventional lung cancer therapies please scroll down the page, post a question or comment and I will reply to you ASAP.

thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Initial Therapy at Academic Centers Linked to Prolonged Overall Survival in NSCLC

“Researchers accessed and compiled the data from the National Cancer Database (NCDB) of 1,150,722 patients with NSCLC and separated them into 2 arms by receipt of initial treatment at an academic center (31.5%) and from a non-academic center (68.5%). Several baseline characteristics were different between the 2 groups, including age, race, comorbidity score, cancer stage, median income, course of treatment, and distance from treatment center…

Patients treated at academic centers also had a lower risk of death (hazard ratio [HR], 0.91; 95% CI, 0.906-0.919; P < .001); 4-year OS rates were 25% and 19% among patients treated at academic and non-academic centers, respectively (P < .001).

The authors concluded that “factors influencing treatment facility choice should be addressed for easier access to academic centers.”

Leave a Comment: